Veru (VERU) Stock Forecast, Price Target & Predictions
VERU Stock Forecast
Veru stock forecast is as follows: an average price target of $4.00 (represents a 554.45% upside from VERU’s last price of $0.61) and a rating consensus of 'Buy', based on 7 wall street analysts offering a 1-year stock forecast.
VERU Price Target
VERU Analyst Ratings
Buy
Veru Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
May 03, 2024 | Yi Chen | H.C. Wainwright | $3.00 | $1.67 | 79.64% | 390.84% |
Apr 15, 2024 | Leland Gershell | Oppenheimer | $5.00 | $1.52 | 228.95% | 718.06% |
Dec 07, 2022 | H.C. Wainwright | $18.00 | $5.66 | 218.02% | 2845.03% | |
Apr 15, 2022 | Leland Gershell | Oppenheimer | $36.00 | $14.95 | 140.80% | 5790.05% |
Veru Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | 2 |
Avg Price Target | - | - | $4.00 |
Last Closing Price | $0.61 | $0.61 | $0.61 |
Upside/Downside | -100.00% | -100.00% | 554.45% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
May 14, 2024 | B. Riley | Buy | Initialise | |
May 06, 2024 | Raymond James | Buy | Buy | Hold |
May 03, 2024 | H.C. Wainwright | Buy | Buy | Hold |
Apr 15, 2024 | Oppenheimer | Outperform | Outperform | Hold |
Jun 07, 2023 | Jefferies | Buy | Hold | Upgrade |
Dec 05, 2022 | Cantor Fitzgerald | Overweight | Overweight | Hold |
Jul 11, 2022 | Oppenheimer | Outperform | Outperform | Hold |
Jul 06, 2022 | Jefferies | Buy | Buy | Hold |
May 13, 2022 | Oppenheimer | Outperform | Outperform | Hold |
May 13, 2022 | Jefferies | Buy | Buy | Hold |
Apr 26, 2022 | Zacks Investment Research | Hold | Downgrade | |
Apr 14, 2022 | Oppenheimer | Outperform | Outperform | Hold |
Veru Financial Forecast
Veru Revenue Forecast
Quarter
Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | $2.14M | $3.86M | $3.34M | $6.59M | $2.51M | $2.59M | $9.60M | $13.03M | $14.14M | $15.65M | $17.66M | $13.34M | $14.62M | $11.75M | $10.32M | $9.94M | $10.58M | $8.73M | $9.73M |
Avg Forecast | $5.19M | $1.70M | $1.90M | $2.10M | $875.00K | $875.00K | $875.00K | $2.98M | $3.56M | $3.50M | $3.00M | $3.90M | $3.95M | $6.21M | $4.33M | $5.07M | $11.55M | $16.67M | $12.21M | $13.84M | $18.17M | $14.10M | $14.29M | $10.92M | $10.61M | $10.74M | $10.97M | $8.77M | $9.17M | $8.06M |
High Forecast | $5.30M | $1.74M | $1.94M | $2.15M | $894.16K | $894.16K | $894.16K | $3.45M | $3.64M | $3.58M | $3.07M | $5.90M | $4.04M | $6.35M | $4.42M | $5.39M | $11.55M | $16.67M | $12.21M | $13.84M | $18.17M | $14.10M | $14.29M | $10.92M | $10.61M | $10.74M | $10.97M | $8.77M | $9.17M | $8.06M |
Low Forecast | $4.85M | $1.59M | $1.78M | $1.96M | $817.52K | $817.52K | $817.52K | $2.36M | $3.33M | $3.27M | $2.80M | $1.90M | $3.69M | $5.81M | $4.04M | $4.26M | $11.55M | $16.67M | $12.21M | $13.84M | $18.17M | $14.10M | $14.29M | $10.92M | $10.61M | $10.74M | $10.97M | $8.77M | $9.17M | $8.06M |
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 5 | 4 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 5 | 4 | 5 | 4 | 4 | 3 | 4 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | 0.55% | 0.98% | 0.54% | 1.52% | 0.49% | 0.22% | 0.58% | 1.07% | 1.02% | 0.86% | 1.25% | 0.93% | 1.34% | 1.11% | 0.96% | 0.91% | 1.21% | 0.95% | 1.21% |
Forecast
Veru EBITDA Forecast
Quarter
Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 5 | 4 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 5 | 4 | 5 | 4 | 4 | 3 | 4 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | $-8.80M | $-11.84M | $4.86M | $-31.62M | $-35.59M | $-44.67M | $-21.70M | $-11.72M | $-4.85M | $-1.81M | $-2.87M | $-1.49M | $767.35K | $2.88M | $-1.33M | $-131.91K | $-1.66M | $-1.32M | $-1.70M |
Avg Forecast | $-3.30M | $-1.08M | $-1.21M | $-1.34M | $-557.34K | $-557.34K | $-557.34K | $-1.89M | $-2.27M | $-2.23M | $-1.91M | $-2.48M | $-2.52M | $-3.96M | $-2.75M | $-3.23M | $-6.79M | $-9.79M | $-1.70M | $-8.13M | $-10.67M | $-8.29M | $-1.54M | $-6.42M | $-6.23M | $-6.31M | $530.91K | $-5.15M | $-5.39M | $-4.73M |
High Forecast | $-3.09M | $-1.01M | $-1.13M | $-1.25M | $-520.73K | $-520.73K | $-520.73K | $-1.51M | $-2.12M | $-2.08M | $-1.79M | $-1.21M | $-2.35M | $-3.70M | $-2.57M | $-2.71M | $-6.79M | $-9.79M | $-1.36M | $-8.13M | $-10.67M | $-8.29M | $-1.24M | $-6.42M | $-6.23M | $-6.31M | $637.09K | $-5.15M | $-5.39M | $-4.73M |
Low Forecast | $-3.38M | $-1.11M | $-1.24M | $-1.37M | $-569.54K | $-569.54K | $-569.54K | $-2.20M | $-2.32M | $-2.28M | $-1.95M | $-3.76M | $-2.57M | $-4.05M | $-2.82M | $-3.43M | $-6.79M | $-9.79M | $-2.04M | $-8.13M | $-10.67M | $-8.29M | $-1.85M | $-6.42M | $-6.23M | $-6.31M | $424.73K | $-5.15M | $-5.39M | $-4.73M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | 3.54% | 4.71% | -1.23% | 11.48% | 11.03% | 6.58% | 2.22% | 6.89% | 0.60% | 0.17% | 0.35% | 0.97% | -0.12% | -0.46% | 0.21% | -0.25% | 0.32% | 0.25% | 0.36% |
Forecast
Veru Net Income Forecast
Quarter
Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 5 | 4 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 5 | 4 | 5 | 4 | 4 | 3 | 4 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | $-8.28M | $-23.77M | $6.31M | $-38.79M | $-36.84M | $-41.02M | $-22.20M | $-14.18M | $-6.38M | $-4.29M | $-2.69M | $-2.85M | $17.23M | $-11.83M | $-3.03M | $-810.51K | $-3.31M | $-3.06M | $-2.77M |
Avg Forecast | $-8.09M | $-8.09M | $-8.09M | $-8.09M | $-8.77M | $-8.77M | $-8.09M | $-10.12M | $-9.98M | $-7.82M | $-7.19M | $-16.19M | $-31.70M | $-27.42M | $-44.85M | $-50.80M | $-44.28M | $-23.42M | $-3.13M | $-13.76M | $-13.47M | $-8.78M | $-2.85M | $-6.95M | $-5.37M | $-4.76M | $-1.28M | $-3.42M | $-7.32M | $-6.34M |
High Forecast | $-7.40M | $-7.40M | $-7.40M | $-7.40M | $-8.02M | $-8.02M | $-6.74M | $-7.59M | $-9.13M | $-7.15M | $-6.58M | $-9.96M | $-28.99M | $-25.08M | $-41.02M | $-40.27M | $-44.28M | $-23.42M | $-2.50M | $-13.76M | $-13.47M | $-8.78M | $-2.28M | $-6.95M | $-5.37M | $-4.76M | $-1.02M | $-3.42M | $-7.32M | $-6.34M |
Low Forecast | $-8.32M | $-8.32M | $-8.32M | $-8.32M | $-9.02M | $-9.02M | $-9.44M | $-11.38M | $-10.26M | $-8.05M | $-7.40M | $-18.67M | $-32.60M | $-28.21M | $-46.12M | $-54.98M | $-44.28M | $-23.42M | $-3.76M | $-13.76M | $-13.47M | $-8.78M | $-3.42M | $-6.95M | $-5.37M | $-4.76M | $-1.53M | $-3.42M | $-7.32M | $-6.34M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | 0.51% | 0.75% | -0.23% | 0.87% | 0.73% | 0.93% | 0.95% | 4.53% | 0.46% | 0.32% | 0.31% | 1.00% | -2.48% | 2.20% | 0.64% | 0.63% | 0.97% | 0.42% | 0.44% |
Forecast
Veru SG&A Forecast
Quarter
Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 5 | 4 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 5 | 4 | 5 | 4 | 4 | 3 | 4 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | $8.30M | $6.77M | $10.90M | $12.83M | $17.55M | $18.29M | $10.76M | $7.40M | $6.72M | $5.92M | $5.56M | $4.81M | $4.38M | $3.46M | $3.48M | $3.81M | $3.75M | $3.69M | $3.55M |
Avg Forecast | $6.82M | $2.23M | $2.50M | $2.76M | $1.15M | $1.15M | $1.15M | $3.91M | $4.68M | $4.60M | $3.94M | $5.12M | $5.19M | $8.17M | $5.68M | $6.66M | $11.95M | $17.25M | $5.29M | $14.33M | $18.80M | $14.59M | $4.81M | $11.30M | $10.98M | $11.11M | $5.99M | $9.07M | $9.49M | $8.34M |
High Forecast | $6.97M | $2.28M | $2.55M | $2.82M | $1.17M | $1.17M | $1.17M | $4.53M | $4.78M | $4.70M | $4.03M | $7.75M | $5.30M | $8.35M | $5.81M | $7.08M | $11.95M | $17.25M | $6.35M | $14.33M | $18.80M | $14.59M | $5.77M | $11.30M | $10.98M | $11.11M | $7.19M | $9.07M | $9.49M | $8.34M |
Low Forecast | $6.37M | $2.09M | $2.33M | $2.58M | $1.07M | $1.07M | $1.07M | $3.11M | $4.37M | $4.30M | $3.68M | $2.50M | $4.85M | $7.63M | $5.31M | $5.60M | $11.95M | $17.25M | $4.23M | $14.33M | $18.80M | $14.59M | $3.85M | $11.30M | $10.98M | $11.11M | $4.80M | $9.07M | $9.49M | $8.34M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | 1.62% | 1.31% | 1.34% | 2.26% | 2.64% | 1.53% | 0.62% | 1.40% | 0.47% | 0.32% | 0.38% | 1.00% | 0.39% | 0.32% | 0.31% | 0.63% | 0.41% | 0.39% | 0.43% |
Forecast
Veru EPS Forecast
Quarter
Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 5 | 4 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 5 | 4 | 5 | 4 | 4 | 3 | 4 |
EPS | - | - | - | - | - | - | - | - | - | - | - | $-0.08 | $-0.28 | $0.07 | $-0.48 | $-0.46 | $-0.51 | $-0.28 | $-0.18 | $-0.08 | $-0.05 | $-0.03 | $-0.04 | $0.25 | $-0.17 | $-0.05 | $-0.01 | $-0.05 | $-0.05 | $-0.04 |
Avg Forecast | $-0.06 | $-0.06 | $-0.06 | $-0.06 | $-0.07 | $-0.07 | $-0.06 | $-0.07 | $-0.07 | $-0.06 | $-0.05 | $-0.12 | $-0.23 | $-0.20 | $-0.33 | $-0.38 | $-0.30 | $-0.16 | $-0.14 | $-0.09 | $-0.09 | $-0.06 | $-0.04 | $-0.05 | $-0.04 | $-0.03 | $-0.04 | $-0.02 | $-0.05 | $-0.04 |
High Forecast | $-0.05 | $-0.05 | $-0.05 | $-0.05 | $-0.06 | $-0.06 | $-0.05 | $-0.06 | $-0.07 | $-0.05 | $-0.05 | $-0.07 | $-0.21 | $-0.19 | $-0.30 | $-0.30 | $-0.30 | $-0.16 | $-0.14 | $-0.09 | $-0.09 | $-0.06 | $-0.04 | $-0.05 | $-0.04 | $-0.03 | $-0.04 | $-0.02 | $-0.05 | $-0.04 |
Low Forecast | $-0.06 | $-0.06 | $-0.06 | $-0.06 | $-0.07 | $-0.07 | $-0.07 | $-0.08 | $-0.08 | $-0.06 | $-0.05 | $-0.14 | $-0.24 | $-0.21 | $-0.34 | $-0.41 | $-0.30 | $-0.16 | $-0.14 | $-0.09 | $-0.09 | $-0.06 | $-0.04 | $-0.05 | $-0.04 | $-0.03 | $-0.04 | $-0.02 | $-0.05 | $-0.04 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | 0.69% | 1.19% | -0.35% | 1.44% | 1.22% | 1.69% | 1.75% | 1.27% | 0.85% | 0.58% | 0.56% | 1.00% | -5.26% | 4.64% | 1.39% | 0.29% | 2.18% | 0.94% | 1.02% |
Forecast
Veru Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
LXRX | Lexicon Pharmaceuticals | $0.83 | $6.00 | 622.89% | Buy |
VERU | Veru | $0.61 | $4.00 | 555.74% | Buy |
ANVS | Annovis Bio | $4.89 | $25.50 | 421.47% | Buy |
NVAX | Novavax | $8.81 | $20.33 | 130.76% | Buy |
IOVA | Iovance Biotherapeutics | $6.07 | $13.50 | 122.41% | Buy |
SRPT | Sarepta Therapeutics | $115.45 | $184.00 | 59.38% | Buy |
MCRB | Seres Therapeutics | $0.81 | $1.25 | 54.32% | Buy |
AXSM | Axsome Therapeutics | $105.14 | $133.40 | 26.88% | Buy |
AVXL | Anavex Life Sciences | $9.70 | $11.00 | 13.40% | Buy |
TSVT | 2seventy bio | $2.49 | $2.00 | -19.68% | Buy |